The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I/II study of preoperative (pre-op) short course chemoradiation (CRT) with proton beam therapy (PBT) and capecitabine (cape) followed by early surgery for resectable pancreatic ductal adenocarcinoma (PDAC) of the head.
Theodore S. Hong
No relevant relationships to disclose
David P. Ryan
No relevant relationships to disclose
Darrell R. Borger
Consultant or Advisory Role - Bio-Reference Laboratories
Lawrence Scott Blaszkowsky
No relevant relationships to disclose
Beow Yong Yeap
No relevant relationships to disclose
Vikram Deshpande
No relevant relationships to disclose
Jennifer Yon-Li Wo
No relevant relationships to disclose
Raymond Couric Wadlow
No relevant relationships to disclose
Eunice Lee Kwak
No relevant relationships to disclose
Jill N. Allen
No relevant relationships to disclose
Jeffrey W. Clark
No relevant relationships to disclose
Andrew X. Zhu
No relevant relationships to disclose
Cristina Ferrone
No relevant relationships to disclose
Harvey J. Mamon
No relevant relationships to disclose
Judith A. Adams
No relevant relationships to disclose
Barbara Winrich
No relevant relationships to disclose
Tarin Grillo
No relevant relationships to disclose
Thomas F. DeLaney
No relevant relationships to disclose
Carlos Fernandez-del Castillo
No relevant relationships to disclose